Medical Membrane Devices Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

The global medical membrane devices market is expected to show lucrative growth over the forecast period, owing to the growing incidences of lifestyle-related chronic diseases such as renal failure, diabetes, and atherosclerosis coupled with rising demand for the membrane devices in the management of diseases. A growing number of applications of the membrane devices such as microfiltration, IV infusion filters, drug delivery, and sterile filtration are expected to show a positive impact on market growth. 

In addition, other non-therapeutic uses such as the recovery of the concentrated proteins and enzymes are anticipated to poise the market growth during the forecast period. Introduction of the new technologies in medical membrane devices, growing awareness, and acceptance of these technologies are other drivers for the growth of the market. Additionally, increasing usage of these membranes in the fields such as water purification, food and beverages are expected to propagate the scope of the membrane devices in the near future.

On the basis of scope, the medical membrane devices market is segmented into therapeutic use and diagnostic use. The therapeutic segment is further classified, on the basis of diseases into renal, cardiovascular, respiratory, and others. The diagnostic segment involves the tools such as proteins and enzymes filter. The therapeutic segment held the largest market share in 2014 owing to the rising prevalence of chronic disease and increasing awareness of physicians about the applications of medical membrane devices in the management of these diseases.

The market share of the diagnostic segment is showing significant growth owing to the introduction of innovative methods. The demand is expected to grow substantially in both segments in the future owing to the technological developments in the area and demand for the more efficient and economical methods for diagnosis and therapeutics of diseases. On the basis of type, the market is segmented into IV filters, dialyzers, blood microfilters, blood oxygenators, and blood/apheresis filters. The blood/apheresis filters dominated the medical membrane device market share in 2014 owing to the growing demand for the blood components such as RBC, WBC, and platelets for the management of various diseases and disorders such as sickle cell anemia and thalassemia.

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA (the Middle East and Africa). In 2014, North America dominated the market owing to the increasing awareness of the people and growing demand for medical membrane devices supported by sophisticated healthcare infrastructure. The dominance of North America is expected to continue in the future owing to the development of technologies in the membrane device.

The Asia Pacific is anticipated to show the fastest growth in this market owing to the rising demand for medical membrane devices with rising disposable income, changing lifestyles associated with chronic diseases, and an increase in the number of dialysis centers in developing countries like India and China. The growing interest of governments in these countries for foreign direct investments in the medical device sector is expected to play an important role in the growth of the medical membrane device market. In addition, increasing favorable government initiatives and programs are expected to boost market growth during the forecast period.

Key players in the medical membrane devices market include Abbott Laboratories, Agilent Technologies, Baxter International Inc, B. Braun Medical Inc. Fresenius Group, Gore, F.Hoffmann-La Roche AG, 3M Company, Aethlon Medical Inc, Becton, Dickinson and Company, Cantel Medical Corporation, Siemens AG, and Johnson & Johnson Services Inc. Aethlon Medical Inc has come up with innovative products like Aethlon ADAPT system, hemopurifier, and HER2osome. The product portfolio of the Medivators, the subsidiary of Cantel Medical Corporation includes products such as hemocore HPH and Renaflo II HF which are majorly used in renal dialysis and therapeutic filtration technologies. Expected commercialization of new products and subsequent acquisitions and mergers of companies involved in the medical devices are the recent trends being observed in the market. For instance, in May 2015, Danahar announced to buy Pall which is involved in the business of purification and separation processes.